Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.

Barter, P J; Ballantyne, C M; Carmena, R; Castro Cabezas, M; Chapman, M John; Couture, P; de Graaf, J; Durrington, P N; Faergeman, O; Frohlich, J; Furberg, C D; Gagne, C; Haffner, S M; Humphries, S E; Jungner, I; Krauss, R M; Kwiterovich, P; Marcovina, S; Packard, C J; Pearson, T A; Reddy, K Srinath; Rosenson, R; Sarrafzadegan, N; Sniderman, A D; Stalenhoef, A F; Stein, E; Talmud, P J; Tonkin, A M; Walldius, G; Williams, K M S

Barter, P J; Ballantyne, C M; Carmena, R; Castro Cabezas, M; Chapman, M John; Couture, P; de Graaf, J; Durrington, P N; Faergeman, O; Frohlich, J; Furberg, C D; Gagne, C; Haffner, S M; Humphries, S E; Jungner, I; Krauss, R M; Kwiterovich, P; Marcovina, S; Packard, C J; Pearson, T A; Reddy, K Srinath; Rosenson, R; Sarrafzadegan, N; Sniderman, A D; Stalenhoef, A F; Stein, E; Talmud, P J; Tonkin, A M; Walldius, G; Williams, K M S.

Affiliation

Barter PJ; Heart Research Institute, Camperdown, Sydney, NSW, Australia.

J Intern Med ; 259(3): 247-58, 2006 Mar.

Article in En | MEDLINE | ID: mdl-16476102

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Apolipoproteins B / Coronary Artery Disease / Cholesterol / Hyperlipidemias / Hypolipidemic Agents Type of study: Clinical_trials / Etiology_studies / Guideline / Risk_factors_studies Limits: Humans Language: En Journal: J Intern Med Journal subject: MEDICINA INTERNA Year: 2006 Document type: Article Affiliation country: Australia Country of publication: Reino Unido

Search on Google

Add to My VHL

XML

PubMed Links